Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody

Conclusion: Dual-labeled A11 cMb specifically visualized PSCA-positive tumor by successive immunoPET/fluorescence, which can potentially be translated for preoperative whole-body prostate cancer detection and intraoperative surgical guidance in patients.

Source: Theranostics - December 7, 2018 Category: Molecular Biology Authors: Wenting K Tsai, Kirstin A Zettlitz, Richard Tavar é , Naoko Kobayashi, Robert E Reiter, Anna M Wu Tags: Research Paper Source Type: research